Literature DB >> 2092041

Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes.

C N Baxevanis1, S Frillingos, K Seferiadis, G J Reclos, P Arsenis, A Katsiyiannis, E Anastasopoulos, O Tsolas, M Papamichail.   

Abstract

The in vitro incubation of phytohemagglutinin (PHA)- or alloantigen-stimulated peripheral blood T cells with prothymosin alpha (ProT alpha) resulted in a marked and reproducible increase in the production of interleukin-2 (IL-2). Incubation of T cells with ProT alpha, in the absence of PHA or alloantigen, failed to induce any production of IL-2. ProT alpha by itself did not exert any IL-2 activity. Finally, ProT alpha was shown to increase the expression of IL-2 receptors on phytohemagglutinin- or alloantigen-activated T cells. These data provide the basis for understanding the in vitro immunoenhancing effects of ProT alpha in cellular immune systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2092041     DOI: 10.3109/08923979009019679

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  8 in total

1.  Zidovudine and thymus humoral factor gamma-2 in the treatment of HIV infection: preliminary clinical experience.

Authors:  F Maggiolo; A Taras; M G Pravettoni; M Leone; A Ingrosso; F Suter
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

2.  A standardized randomized 6-month aerobic exercise-training down-regulated pro-inflammatory genes, but up-regulated anti-inflammatory, neuron survival and axon growth-related genes.

Authors:  Osigbemhe Iyalomhe; Yuanxiu Chen; Joanne Allard; Oyonumo Ntekim; Sheree Johnson; Vernon Bond; David Goerlitz; James Li; Thomas O Obisesan
Journal:  Exp Gerontol       Date:  2015-05-15       Impact factor: 4.032

Review 3.  Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.

Authors:  Anastasios I Birmpilis; Antonios Paschalis; Apostolis Mourkakis; Panayiota Christodoulou; Ioannis V Kostopoulos; Elina Antimissari; Georgia Terzoudi; Alexandros G Georgakilas; Christina Armpilia; Panagiotis Papageorgis; Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos; Hubert Kalbacher; Evangelia Livaniou; Maria-Ioanna Christodoulou; Ourania E Tsitsilonis
Journal:  Cells       Date:  2022-04-22       Impact factor: 7.666

4.  Potential Role of Thymosin-alpha1 Adjuvant Therapy for Glioblastoma.

Authors:  Arno Sungarian; Deus Cielo; Prakash Sampath; Nathaniel Bowling; Peter Moskal; Jack R Wands; Suzanne M de la Monte
Journal:  J Oncol       Date:  2010-01-11       Impact factor: 4.375

5.  Identification of differentially expressed genes of brown trout (Salmo trutta) and rainbow trout (Oncorhynchus mykiss) in response to Tetracapsuloides bryosalmonae (Myxozoa).

Authors:  Gokhlesh Kumar; Ahmed Abd-Elfattah; Mansour El-Matbouli
Journal:  Parasitol Res       Date:  2015-01-07       Impact factor: 2.289

6.  The macrophage-derived protein PTMA induces filamentation of the human fungal pathogen Candida albicans.

Authors:  Nicola T Case; Kwamaa Duah; Brett Larsen; Cassandra J Wong; Anne-Claude Gingras; Teresa R O'Meara; Nicole Robbins; Amanda O Veri; Luke Whitesell; Leah E Cowen
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

Review 7.  Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?

Authors:  P Samara; K Ioannou; O E Tsitsilonis
Journal:  Vitam Horm       Date:  2016-05-27       Impact factor: 3.421

8.  Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.

Authors:  Anastasios I Birmpilis; Chrysoula-Evangelia Karachaliou; Pinelopi Samara; Kyriaki Ioannou; Platon Selemenakis; Ioannis V Kostopoulos; Nadia Kavrochorianou; Hubert Kalbacher; Evangelia Livaniou; Sylva Haralambous; Athanasios Kotsinas; Farzin Farzaneh; Ioannis P Trougakos; Wolfgang Voelter; Meletios-Athanasios Dimopoulos; Aristotelis Bamias; Ourania Tsitsilonis
Journal:  Cancers (Basel)       Date:  2019-11-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.